In Reply — Immune Checkpoint Inhibitor–Induced Type 1 Diabetes: An Underestimated Risk

Mayo Clinic Proceedings - Netherlands
doi 10.1016/j.mayocp.2019.12.010
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV

Related search

Immune Checkpoint Inhibitor‐induced Type 1 Diabetes: A Systematic Review and Meta‐analysis

Diabetic Medicine
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

Immune Checkpoint Inhibitor-Induced Fanconi Syndrome

Cureus
2020English

Reporting of Immune Checkpoint Inhibitor-Associated Myocarditis – Authors' Reply

The Lancet
Medicine
2018English

Letter: Immune Checkpoint Inhibitor-Induced Colitis-Shouldn't We Be Checking More Often? Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2019English

The Sexual Dysfunction in Females With Type 1 Diabetes: Still an Underestimated Issue?

Diabetes Updates
2019English

Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review

Internal Medicine
Internal MedicineMedicine
2019English

Immune Intervention in Type 1 Diabetes

Diabetes Technology and Therapeutics
MedicineEndocrinologyMedical Laboratory TechnologyMetabolismDiabetes
2020English

Immune Checkpoint Inhibitors and Type 1 Diabetes Mellitus: A Case Report and Systematic Review

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2019English

Can an Immune Checkpoint Inhibitor (Sometimes) Make Things Worse?

Clinical Cancer Research
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy